FREE THE PILL
Mother Jones|November/December 2022
The FDA is poised to approve the first over-the-counter birth control. What took so long?
JACKIE FLYNN MOGENSEN
FREE THE PILL

IF YOU'RE ONE of the estimated 10 million people in the United States taking oral contraception, you probably needed a prescription to get it. But that could soon change: In July, a Paris-based company, HRA Pharma, announced it asked the US Food and Drug Administration for permission to sell its progestin-only birth control pill over the counter. For the first time since its approval in 1960, the Pill may be available with no requirement to consult a health care professional-a significant hurdle for those most in need of the medication.

The US wouldn't be the first country to #FreeThePill; in fact, oral contraceptives are available without a prescription in more than 100 countries. That's because the Pill is nearly 100 percent effective when taken regularly, and safe for most people. Blood clots, a risk associated with the drug, are serious, but rare in today's formulations: Every year, between one and five out of 10,000 women who are not on hormonal birth control or pregnant experience a blood clot; for people on the combination (estrogen and progestin) pill, the risk rises to between three and nine out of 10,000 people. And there's no increased risk of clots for those on a progestin-only pill. In recent years, dozens of US medical organizations have declared support for a nonprescription pill, and an overwhelming majority of voters appear to be in favor of making the change.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM MOTHER JONESView all
WHEN IN DROUGHT
Mother Jones

WHEN IN DROUGHT

This obscure yet adaptable grain could be a healthy staple for a warming planet.

time-read
3 mins  |
November/December 2024
GLOBAL WARNING
Mother Jones

GLOBAL WARNING

Why Project 2025 is an environmental catastrophe in the making

time-read
5 mins  |
November/December 2024
BAD HABITS
Mother Jones

BAD HABITS

A spate of recent horror movies recycle tired tropes about nuns-and reveal society's ongoing discomfort with independent women.

time-read
9 mins  |
November/December 2024
Taking the Fifth For a glimpse of the Supreme Court after a second Trump term, look at the radical circuit court that's already driving America to the right.
Mother Jones

Taking the Fifth For a glimpse of the Supreme Court after a second Trump term, look at the radical circuit court that's already driving America to the right.

Imagine obamacare is dead and millions of Americans have lost health coverage.

time-read
10+ mins  |
November/December 2024
THE ARCHITECT
Mother Jones

THE ARCHITECT

TRUMP WANTS TO BE KING. RUSS VOUGHT HAS A PLAN TO MAKE IT HAPPEN.

time-read
10+ mins  |
November/December 2024
Losing Faith
Mother Jones

Losing Faith

As an evangelical leader, I enticed lawmakers and federal judges to adopt a conservative Christian agenda. Donald Trump’s rise proved how wrong I was.

time-read
10+ mins  |
November/December 2024
GOD'S COUNTRY
Mother Jones

GOD'S COUNTRY

These Christian nationalists have a plan to take over Americafrom small towns to the highest court in the land.

time-read
10+ mins  |
November/December 2024
IN THE NAME OF THE MOTHER
Mother Jones

IN THE NAME OF THE MOTHER

How Shyamala Gopalan Harris raised a presidential contender

time-read
6 mins  |
November/December 2024
KILL THE MESSENGER
Mother Jones

KILL THE MESSENGER

The anti-disinformation field is retreating under attack.

time-read
6 mins  |
November/December 2024
TRUMPNESIA
Mother Jones

TRUMPNESIA

To get a second chance, Trump needs voters to forget his disastrous presidency.

time-read
6 mins  |
November/December 2024